Le Lézard
Classified in: Health, Science and technology, Business
Subject: VEN

Kindbody Raises $32 Million in Series B Funding to Grow Employer Benefits Solution and Fuel U.S. Expansion


NEW YORK, July 8, 2020 /PRNewswire/ -- Kindbody, a fast growing health and technology company providing fertility, gynecology, and family-building care, today announced $32 million in Series B funding, bringing its total amount raised to $64 million.

Kindbody offers end-to-end services from preconception through postpartum, serving as both a provider and network solution. Their offering covers fertility treatment, including IVF and egg freezing, as well as gynecology, wellness, and LGBTQ+ services. Their approach features direct purchasing and inclusive bundled-rates, which allows Kindbody to offer pricing up to 30% less than other fertility benefit programs.

The Series B round was led by Perceptive Advisors, with participation from existing investors RRE, GV (formerly Google Ventures), and Freemark Capital. New investors include major private and public healthcare funds Rock Springs Capital, Goodgrower and Claritas Capital as well as benefits consulting firm, NFP. The funds will be used to expand Kindbody's national footprint and build an international presence, through brick-and-mortar locations and a growing "Center of Excellence" (COE) network of partner clinics.

Kindbody leverages proprietary technology to deliver a seamless member experience and data-driven results at its 180+ Kindbody and COE locations. The Company works with employers as a full-service benefits solution to deliver a premium experience with significant costs savings, and directly with patients, as an accessible, inclusive provider.

"You must be in the provision of services - in the actual care delivery business - to effectuate change in member experience, outcomes and costs. Sophisticated employers know this and are helping to drive change, utilizing their buying power to control costs. We're fortunate to have blue-chip investors to help accelerate this," said Founder and CEO, Gina Bartasi. Adding, "The funds allow us to scale the infrastructure - in terms of people and process - required to execute on large accounts. We're adding depth to our outstanding team at almost every level."

"We've followed Gina's career since her time at Progyny and trust her veteran leadership to not only navigate through the global pandemic, but show tremendous growth. June's patient volume is up 30% from pre-Covid levels - which speaks to the resilience of the business, and the interest from employers, which we see as a huge opportunity going forward," said Ellen Hukkelhoven, Managing Director, Perceptive Advisors.

Kindbody's clinical team is led by Chief Medical Officer, Dr. Lynn Westphal, the former head of Stanford Medicine's Third-Party and Fertility Preservation Program, and Founding Ob/Gyn, Dr. Fahimeh Sasan, previously at Mount Sinai. Their corporate team includes President Annbeth Eschbach, Chief Operating Officer Patty Stull, Chief Business and Legal Officer, Shilpa Patel and Chief Financial Officer, Debbie Markowitz.

About Kindbody
Kindbody provides fertility, gynecology, and family-building services at Kindbody clinics and a network of high quality partner clinics. As both a provider and network solution, Kindbody serves patients and employers at 180+ locations, leveraging proprietary technology to deliver a seamless end-to-end experience. Kindbody offers superior outcomes at significantly lower prices, with a mission to increase access to care and deliver a more welcoming, inclusive experience.

Media Inquiries:
Rebecca Silver, Vice President, Brand Marketing
[email protected]
1-855-563-2639

SOURCE Kindbody


These press releases may also interest you

at 20:31
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

at 19:35
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

at 18:36
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...

at 17:53
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit: All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...



News published on and distributed by: